Q98407534

Summary

Q98407534 is a report^[1].

Key Facts

• Q98407534's instance of is recorded as report^[2].
• Q98407534's part of the series is recorded as reports of the 2017/18 legislative session of the Riksdag^[3].
• Q98407534's language of work or name is recorded as Swedish^[4].
• Q98407534 was published on +2018-05-28T00:00:00Z^[5].
• Q98407534's main subject is medication^[6].
• Q98407534's work available at URL is recorded as http://data.riksdagen.se/dokument/H501SoU29^[7].
• Q98407534's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H501SoU29^[8].
• Q98407534's work available at URL is recorded as http://data.riksdagen.se/fil/A3E6BB94-FC9C-4C62-A462-0B701220795F^[9].
• Q98407534's applies to jurisdiction is recorded as Sweden^[10].
• Q98407534's legal citation of this text is recorded as bet. 2017/18:SoU29^[11].
• Q98407534's title is recorded as Anpassningar av svensk rätt till EU-förordningen om kliniska läkemedelsprövningar^[12].
• Q98407534's has immediate cause is recorded as Q98120440^[13].
• Q98407534's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q98407534's copyright status is recorded as public domain^[15].
• Q98407534's legislative committee is recorded as Committee on Health and Welfare^[16].

Body

Definition and Type

Q98407534's instance of is recorded as report^[2].